These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7485095)

  • 1. Serum hyaluronan is increased in malignant lymphoma.
    Hasselbalch H; Hovgaard D; Nissen N; Junker P
    Am J Hematol; 1995 Dec; 50(4):231-3. PubMed ID: 7485095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma.
    Mäenpää H; Ristamäki R; Virtamo J; Franssila K; Albanes D; Joensuu H
    Leuk Lymphoma; 2000 May; 37(5-6):585-92. PubMed ID: 11042519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyaluronan and CD44 in maternal serum in pre-eclampsia].
    Matejevic D; Bussen S; Steck T; Müller T; Dietl J
    Z Geburtshilfe Neonatol; 1999; 203(6):246-9. PubMed ID: 10612197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
    Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
    Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucocyte zinc in non-Hodgkin's lymphoma and Hodgkin's disease.
    Field HP; Jones R; Walker BE; Kelleher J; Simmons AV
    Nutr Cancer; 1988; 11(2):83-92. PubMed ID: 3362723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration.
    Dahl IM; Turesson I; Holmberg E; Lilja K
    Blood; 1999 Jun; 93(12):4144-8. PubMed ID: 10361111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Lindqvist U; Engström Laurent A
    Am J Hematol; 1991 Jan; 36(1):1-8. PubMed ID: 1984676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osteopontin and CD44 levels in lymphoreticular malignancies in children.
    Elli M; Dagdemir A; Bozkurt C; Pinarli FG; Duzgun A; Ozmen ZC; Ertem U; Acar S
    Bratisl Lek Listy; 2012; 113(9):534-8. PubMed ID: 22979908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum selenium levels in untreated children with acute lymphoblastic leukemia. I.
    Mikac-Dević M; Ferenec D; Tiefenbach A
    J Trace Elem Electrolytes Health Dis; 1990 Mar; 4(1):7-10. PubMed ID: 2135960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Celiac disease in Hodgkin and non-Hodgkin lymphoma patients.
    Cil T; Altintaş A; Işikdoğan A; Paşa S; Bayan K; Batun S; Büyükbayram H
    Turk J Gastroenterol; 2009 Jun; 20(2):87-92. PubMed ID: 19530040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoli of blood monocytes in malignant lymphoma. A morphometric study.
    Sokol RJ
    Am J Clin Pathol; 1989 Jan; 91(1):60-3. PubMed ID: 2910016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ferritin in the serum of patients with Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma and polycythemia vera].
    Kardaszewicz S; Rusinowska Z; Skałba P; Kokocińska D
    Pol Tyg Lek; 1988 Feb; 43(7):214-6. PubMed ID: 3405891
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma.
    Thylén A; Wallin J; Martensson G
    Cancer; 1999 Nov; 86(10):2000-5. PubMed ID: 10570424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
    Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
    Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
    Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
    Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of serum B-lymphocyte stimulator in Hodgkin's lymphoma.
    Oki Y; Georgakis GV; Migone TS; Kwak LW; Younes A
    Haematologica; 2007 Feb; 92(2):269-70. PubMed ID: 17296586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.